SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-19-098543
Filing Date
2019-04-05
Accepted
2019-04-05 09:00:33
Documents
2
Group Members
BALAJI VENKATARAMANLTE MANAGEMENT, LLCLTE PARTNERS, LLCMELKONIAN CAPITAL MANAGEMENT, LLCRYAN MELKONIANVELAN CAPITAL, L.P.VIRINDER NOHRIA

Document Format Files

Seq Description Document Type Size
1 SC 13D d700852dsc13d.htm SC 13D 192383
2 EX-99.1 d700852dex991.htm EX-99.1 8716
  Complete submission text file 0001193125-19-098543.txt   202863
Mailing Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007 646-975-2500
PROGENICS PHARMACEUTICALS INC (Subject) CIK: 0000835887 (see all company filings)

IRS No.: 133379479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-52343 | Film No.: 19733569
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1055B POWERS PLACE SUITE 810 ALPHARETTA GA 30009
Business Address 5348 VEGAS DR., UNIT 733 LAS VEGAS NV 89108 404-664-3629
Altiva Management Inc. (Filed by) CIK: 0001772491 (see all company filings)

IRS No.: 821992901 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D